Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42 | 170 | 36 | 0 | 11 |
| Receivables | N/A | 50 | N/A | N/A | 10 |
| Inventories | N/A | N/A | N/A | N/A | 6 |
| TOTAL | $316 | $220 | $36 | $0 | $27 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 25 |
| Intangibles | 10 | 0 | 0 | 0 | 0 |
| TOTAL | $10 | $N/A | $N/A | $N/A | $25 |
| Total Assets | $326 | $220 | $36 | $0 | $52 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 655 | 168 | 34 | 1 | 231 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 27 |
| Other current liabilities | N/A | N/A | N/A | N/A | 5 |
| TOTAL | $2,268 | $1,019 | $262 | $1 | $342 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 62 | 0 | 0 | 0 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,268 | $1,019 | $262 | $1 | $342 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 100,750 | 88,026 | 85,104 | 105,416 | N/A |
| Common Shares | 98 | 87 | 85 | 85 | 28 |
| Retained earnings | -4,722 | -2,241 | -383 | -86 | -13,883 |
| Other shareholders' equity | 888 | 0 | 0 | 0 | 0 |
| TOTAL | $-1,941 | $-799 | $-225 | $-1 | $-291 |
| Total Liabilities And Equity | $326 | $220 | $36 | $0 | $52 |